Table 3. Summary of the association of NLR and clinopathological parameters in cervical cancer.
| Category | n | Model | OR (95% CI) | Z | P | Heterogeneity | |
|---|---|---|---|---|---|---|---|
| I2 | Ph | ||||||
| Histologic grade (poor vs. well or moderate) | 5 (916) | Random | 1.317 (0.968–.792) | 1.75 | 0.080 | 54.0% | 0.069 |
| Tumor size (≥ 4 cm vs. < 4 cm) | 6 (1151) | Random | 1.780 (1.090–2.908) | 2.30 | 0.021 | 66.3% | 0.011 |
| Clinical stage (III or IV vs.I or II) | 4 (1437) | Fixed | 2.443 (1.730–3.451) | 5.07 | < 0.001 | 0.0% | 0.768 |
| Lymph node metastasis (positvie vs. negative) | 6 (998) | Fixed | 2.380 (1.775–3.190) | 5.79 | < 0.001 | 0.0% | 0.515 |
| Histologic type (SCC vs. non SCC) | 6 (2173) | Fixed | 1.007 (0.792–1.281) | 0.06 | 0.955 | 0.0% | 0.421 |
P denotes P value for statistical significance based on Z test; Ph denotes P value for heterogeneity based on Q test. OR odds ratio; CI confidence interval; SCC squamous cell carcinoma.